000 | 01321 a2200409 4500 | ||
---|---|---|---|
005 | 20250512100912.0 | ||
264 | 0 | _c19680906 | |
008 | 196809s 0 0 rus d | ||
022 | _a0003-5637 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVaĭsberg, G E | |
245 | 0 | 0 |
_a[Experimental-clinical study of combined use of antibiotics and prodigiozan]. _h[electronic resource] |
260 |
_bAntibiotiki _cNov 1967 |
||
300 |
_a1040-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aErythromycin Ethylsuccinate _xtoxicity |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes _xdrug effects |
650 | 0 | 4 |
_aLeukocytosis _xchemically induced |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOophoritis _xdrug therapy |
650 | 0 | 4 |
_aPhagocytosis _xdrug effects |
650 | 0 | 4 |
_aPolymyxins _xtoxicity |
650 | 0 | 4 |
_aPolysaccharides, Bacterial _xpharmacology |
650 | 0 | 4 |
_aSalpingitis _xdrug therapy |
650 | 0 | 4 | _aSerratia marcescens |
650 | 0 | 4 |
_aSuppuration _xdrug therapy |
700 | 1 | _aTaranenko, L A | |
700 | 1 | _aZhukovskaia, L N | |
773 | 0 |
_tAntibiotiki _gvol. 12 _gno. 11 _gp. 1040-3 |
|
999 |
_c4303607 _d4303607 |